Home » Topics » Conferences

Conferences
RSS

Moxisylyte recommended as first-line therapy for erectile dysfunction

April 15, 1997

Transurethral alprostadil/prazosin for erectile dysfunction

April 15, 1997

Mechanism of impaired erection with finasteride elucidated

April 15, 1997

In vitro antitumor activity of lactoferrin

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Eisai prepares potent antitumor agents

April 11, 1997

TX-1877: new hypoxic cell radiation enhancer

April 11, 1997

Fujisawa describes new oral cephem antibiotic

April 11, 1997

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

MDR-reversing agents described by Nikken Chemicals

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...